{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:34:34Z","timestamp":1789619674714,"version":"build-2803163510"},"reference-count":328,"publisher":"Hamad bin Khalifa University Press (HBKU Press)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5,1]]},"abstract":"<jats:p>Vitiligo is an acquired pigmentry disorder of the skin and mucous membranes which manifests as white macules and patches due to selective loss of melanocytes. Etiological hypotheses of vitiligo include genetic, immunological, neurohormonal, cytotoxic, biochemical, oxidative stress and newer theories of melanocytorrhagy and decreased melanocytes survival. There are several types of vitiligo which are usually diagnosed clinically and by using a Wood's lamp; also vitiligo may be associated with autoimmune diseases, audiological and ophthalmological findings or it can be a part of polyendocrinopathy syndromes. Several interventions are available for the treatment for vitiligo to stop disease progression and\/or to attain repigmentation or even depigmentation. In this article, we will present an overall view of current standing of vitiligo research work especially in the etiological factors most notably the genetic components, also, types and associations and various and newer treatment modalities.<\/jats:p>","DOI":"10.5339\/qmj.2013.10","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T12:09:57Z","timestamp":1387800597000},"source":"Crossref","is-referenced-by-count":27,"title":["Concise review of recent studies in vitiligo"],"prefix":"10.5339","volume":"2013","author":[{"given":"Mohamed","family":"Allam","sequence":"first","affiliation":[{"name":"1Dermatology Department, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Riad","sequence":"additional","affiliation":[{"name":"2Dermatology Department, Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3277","reference":[{"key":"CIT0001","series-title":"Taiieb A: Vitiligo","author":"Picardo\n\u00a0\nM","year":"2010"},{"key":"CIT0002","series-title":"Fitzpatric's Dermatology in General Medicine","article-title":"Norris DA: Vitiligo","author":"Birlea\n\u00a0\nSA","year":"in press"},{"key":"CIT0003","series-title":"Pigment Cell Res","first-page":"208","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their relatives","volume":"16","author":"Alkhateeb\n\u00a0\nA","year":"2003"},{"key":"CIT0004","series-title":"Int J Dermatol","first-page":"328","article-title":"Case detection rates of vitiligo by gender and age","volume":"48","author":"Kyriakis\n\u00a0\nKP","year":"2009"},{"key":"CIT0005","series-title":"J Am Acad Dermatol","first-page":"473","article-title":"Vitiligo: A comprehensive overview Part 1. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work up","volume":"65","author":"Alikhan\n\u00a0\nA","year":"2011"},{"key":"CIT0006","series-title":"The Pigmentry System","first-page":"513","article-title":"Vitiligo Vulgaris","author":"Nordlund\n\u00a0\nJJ","year":"1993"},{"key":"CIT0007","series-title":"Vitiligo","author":"Hann\n\u00a0\nS-K","year":"2000"},{"key":"CIT0008","series-title":"J Dermatol Science","first-page":"3","article-title":"The genetics of generalized vitiligo and associated autoimmune diseases","volume":"41","author":"Spritz\n\u00a0\nRA","year":"2006"},{"key":"CIT0009","series-title":"Arch Dermatol","first-page":"1062","article-title":"Characteristics of patients with universal vitiligo and health related quality of life","volume":"144","author":"Linthorst Homan\n\u00a0\nMW","year":"2008"},{"key":"CIT0010","series-title":"J Am Acad Dermatol","first-page":"621","article-title":"An epidemiologic case-control study in a population with vitiligo","volume":"33","author":"Barona\n\u00a0\nMI","year":"1995"},{"key":"CIT0011","series-title":"Fitzpatrick's dermatology in general medicine","first-page":"72","article-title":"Vitiligo","author":"Halder\n\u00a0\nRM","year":"2008"},{"key":"CIT0012","series-title":"Vitiligo","first-page":"155","article-title":"Genetics","author":"Spritz\n\u00a0\nRA","year":"2010"},{"key":"CIT0013","series-title":"Pigment Cell Res","first-page":"208","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb\n\u00a0\nA","year":"2003"},{"key":"CIT0014","series-title":"J Am Acad Dermatol","first-page":"671","article-title":"Segmental vitiligo: clinical findings in 208 patients","volume":"35","author":"Hann\n\u00a0\nSK","year":"1996"},{"key":"CIT0015","series-title":"Pigment Cell Res","first-page":"322","article-title":"A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?","volume":"16","author":"Gauthier\n\u00a0\nY","year":"2003"},{"key":"CIT0016","series-title":"Exp Dermatol","first-page":"145","article-title":"Review of the etiopathomechanism of vitiligo: a convergence theory","volume":"2","author":"Le Poole\n\u00a0\nIC","year":"1993"},{"key":"CIT0017","series-title":"J Am Acad Dermatol","first-page":"52","article-title":"Topical tacrolimus therapy in vitiligo: Therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","volume":"51","author":"Grimes\n\u00a0\nPE","year":"2004"},{"key":"CIT0018","series-title":"Br J Dermatol","first-page":"1275","article-title":"Gene expression study of IL10 family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera","volume":"159","author":"R\u00e4step\n\u00a0\nR","year":"2008"},{"key":"CIT0019","series-title":"Human Immunol","first-page":"393","article-title":"The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells","volume":"73","author":"Reimann\n\u00a0\nE","year":"2012"},{"key":"CIT0020","series-title":"J Histochem Cytochem","first-page":"125","article-title":"Melanocyte function and its control by melanocortin peptides","volume":"50","author":"Stimuli\n\u00a0\nM","year":"2002"},{"key":"CIT0021","series-title":"J Lab Clin Med","first-page":"658","article-title":"Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin","volume":"122","author":"Slominski\n\u00a0\nA","year":"1993"},{"key":"CIT0022","series-title":"Peptides","first-page":"813","article-title":"MSH peptides are present in mammalian skin","volume":"4","author":"Thody\n\u00a0\nAJ","year":"1983"},{"key":"CIT0023","series-title":"Neuropeptides","first-page":"177","article-title":"Vitiligo patients present lower plasma levels of alpha melanotropin immunoreactivities","volume":"40","author":"Pichler\n\u00a0\nR","year":"2006"},{"key":"CIT0024","series-title":"Ann NY Acad Sci","first-page":"470","article-title":"The expression of alpha-MSH by melanocytes is reduced in vitiligo","volume":"885","author":"Graham\n\u00a0\nA","year":"1999"},{"key":"CIT0025","series-title":"J Dermatol Sci","first-page":"113","article-title":"Gene expression analysis of melanocortin system in vitiligo","volume":"48","author":"Kingo\n\u00a0\nK","year":"2007"},{"key":"CIT0026","series-title":"J Investig Dermatol","first-page":"798","article-title":"Genome wide-association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8","volume":"130","author":"Birlea\n\u00a0\nSA","year":"2010"},{"key":"CIT0027","series-title":"N Engl J Med","first-page":"1686","article-title":"Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo","volume":"362","author":"Jin\n\u00a0\nY","year":"2010"},{"key":"CIT0028","series-title":"Nat Genet","first-page":"576","article-title":"Common variants of FOXP1 are associated with generalized vitiligo","volume":"42","author":"Jin\n\u00a0\nY","year":"2010"},{"key":"CIT0029","series-title":"Nat Genet","first-page":"614","article-title":"Genome wide-association study for vitiligo identifies susceptibility loci at 6q27 and MHC","volume":"42","author":"Quan\n\u00a0\nC","year":"2010"},{"issue":"9","key":"CIT0030","series-title":"J Eur Acad Dermatol Venereol","first-page":"1137","article-title":"A single nucleotide polymorphism rs9468925 of MHC region is associated with clinical features of generalized vitiligo in Chinese Han population","volume":"26","author":"Liu\n\u00a0\nJ","year":"2012"},{"key":"CIT0031","series-title":"Genome Med","first-page":"78","article-title":"The genetics of generalized vitiligo: autoimmune pathways and inverse relation with malignant melanoma","volume":"2","author":"Spritz\n\u00a0\nLA","year":"2010"},{"key":"CIT0032","series-title":"J Invest Dermatol","first-page":"371","article-title":"Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, AND TSLP","volume":"131","author":"Birlea\n\u00a0\nSA","year":"2011"},{"issue":"8","key":"CIT0033","series-title":"Arch Dermatol Res","first-page":"631","article-title":"Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs","volume":"302","author":"Alkhateeb\n\u00a0\nA","year":"2010"},{"key":"CIT0034","series-title":"J Invest Dermatol","first-page":"774","article-title":"Fine-mapping of vitiligo susceptibility loci on chromosome 7 and 9 and interactions with NLRP1 (NALP1)","volume":"130","author":"Jin\n\u00a0\nY","year":"2010"},{"key":"CIT0035","series-title":"Pigment Cell Res","first-page":"90","article-title":"Evidence of an autoimmune pathogenesis of vitiligo","volume":"16","author":"Ongenae\n\u00a0\nK","year":"2003"},{"key":"CIT0036","series-title":"Autoimmun Rev","first-page":"762","article-title":"Immunopathogenesis of vitiligo","volume":"10","author":"Sandoval-Cruz\n\u00a0\nM","year":"2011"},{"key":"CIT0037","series-title":"J Autoimmun","first-page":"63","article-title":"Pathophysiology and genetics of vitiligo","volume":"25","author":"Passeron\n\u00a0\nT","year":"2005"},{"issue":"7","key":"CIT0038","series-title":"Autoimmun Rev","first-page":"516","article-title":"Current remedies for vitiligo","volume":"9","author":"Abu Tahir\n\u00a0\nM","year":"2010"},{"key":"CIT0039","series-title":"Pak J Pharm Sci","first-page":"96","article-title":"Immunoglobulin levels in vitiligo patients","volume":"23","author":"Ali\n\u00a0\nR","year":"2010"},{"key":"CIT0040","series-title":"J Invest Dermatol","first-page":"969","article-title":"IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule 1expression and increased IL-8 release by melanocytes","volume":"115","author":"Li\n\u00a0\nYL","year":"2000"},{"key":"CIT0041","series-title":"Autoimmun Rev","first-page":"138","article-title":"Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo","volume":"3","author":"Kemp\n\u00a0\nEH","year":"2007"},{"key":"CIT0042","series-title":"Medical Hypotheses","first-page":"67","article-title":"The Double Strike hypothesis of the vitiligo pathomechanism: New approaches to vitiligo and melanoma","volume":"74","author":"Michelsen\n\u00a0\nD","year":"2010"},{"key":"CIT0043","series-title":"Pigment Cell Melanoma Res","first-page":"276","article-title":"Reduced skin homing by functional Treg in vitiligo","volume":"23","author":"Klarquist\n\u00a0\nJ","year":"2010"},{"key":"CIT0044","series-title":"Pigment Cell Melanoma Res","first-page":"375","article-title":"First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi","volume":"23","author":"van Geel\n\u00a0\nNAC","year":"2010"},{"key":"CIT0045","series-title":"PloS ONE","first-page":"1","article-title":"Global Activation of CD8+ Cytotoxic T Lymphocytes Correlates with an Impairment in Regulatory T Cells in Patients with Generalized Vitiligo","volume":"7","author":"Lili\n\u00a0\nY","year":"2012"},{"key":"CIT0046","series-title":"Pigment Cell Melanoma Res","first-page":"602","article-title":"Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells","volume":"25","author":"Zhou\n\u00a0\nL","year":"2012"},{"key":"CIT0047","series-title":"Vitiligo","article-title":"Autocytotoxic hypothesis for the destruction of melanocytes as the cause of vitiligo","author":"Hann\n\u00a0\nSK","year":"2000"},{"key":"CIT0048","series-title":"J Invest Dermatol","first-page":"1081","article-title":"Low catalase level in the epidermis in patients with vitiligo","volume":"97","author":"Schallreuter\n\u00a0\nKU","year":"1991"},{"key":"CIT0049","series-title":"J Inest Dermatol Sym Proc","first-page":"91","article-title":"In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation IN THE EPIDERMIS of patients with vitiligo and its successful removal by UVB-activated pseudocatalase","volume":"4","author":"Schallreuter\n\u00a0\nKU","year":"1999"},{"key":"CIT0050","series-title":"Pigment Cell Res","first-page":"62","article-title":"Genetic association of the catalase gene (CAT) with vitiligo susceptibility","volume":"15","author":"Casp\n\u00a0\nCB","year":"2002"},{"key":"CIT0051","series-title":"Clinical Science","first-page":"99","article-title":"Vitiligo, reactive oxygen species and T-cells","volume":"120","author":"Glassman\n\u00a0\nSJ","year":"2011"},{"key":"CIT0052","series-title":"Science","first-page":"1444","article-title":"Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin","volume":"263","author":"Schallreuter\n\u00a0\nKU","year":"1994"},{"key":"CIT0053","series-title":"Biochem Biophys Res Commun","first-page":"43","article-title":"Cytotoxicity of 6-biopterin to human melanocytes","volume":"204","author":"Schallreuter\n\u00a0\nKU","year":"1994"},{"key":"CIT0054","series-title":"Br J Dermatol","first-page":"171","article-title":"Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion","volume":"137","author":"Le Poole\n\u00a0\nIC","year":"1997"},{"key":"CIT0055","series-title":"J Pathol","first-page":"465","article-title":"Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: rple od SCF\/KIT interactions and the downstream effector MITF-M","volume":"202","author":"Kitamura\n\u00a0\nR","year":"2004"},{"key":"CIT0056","series-title":"J Invest Dermatol","first-page":"976","article-title":"Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may lead to may cause passive melanocyte death in vitiligo","volume":"123","author":"Lee\n\u00a0\nAY","year":"2005"},{"key":"CIT0057","series-title":"Pigment Cell Melanoma Res","first-page":"E1","article-title":"Vitiligo Global Issue Consensus Conference Panelists. Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine\n\u00a0\nK","year":"2012"},{"key":"CIT0058","series-title":"J Am Acad Dermatol","first-page":"945","article-title":"Segmental and nonsegmental childhood vitiligo have distinct clinical characteristics: A prospective observational study","volume":"62","author":"Mazereeuw-Hautier\n\u00a0\nJ","year":"2010"},{"key":"CIT0059","series-title":"J Eur Acad Dermatol Venereol","first-page":"673","article-title":"Different phenotypes of segmental vitiligo based on a clinical observational study","volume":"25","author":"van Geel\n\u00a0\nN","year":"2011"},{"key":"CIT0060","series-title":"Eur Acad Dermatol Venereol","first-page":"105","article-title":"Vitiligo and autoimmunity: an epidemiological study in a representative sample of young Italian males","volume":"1","author":"Ingordo\n\u00a0\nV","year":"2011"},{"key":"CIT0061","series-title":"J Eur Acad Dermatol Venereol","first-page":"1144","article-title":"Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey","volume":"24","author":"Akay\n\u00a0\nBN","year":"2010"},{"key":"CIT0062","series-title":"Otolaryngol Head Neck Surg","first-page":"409","article-title":"Audiological and transient evoked otoacoustic emission findings in patients with vitiligo","volume":"142","author":"Aslan\n\u00a0\nS","year":"2010"},{"key":"CIT0063","series-title":"Dermatology","first-page":"901","article-title":"Melanocyte biology","author":"Bolognia\n\u00a0\nJL","year":"2008"},{"key":"CIT0064","series-title":"Acta Otolaryngol","first-page":"17","article-title":"Pigment anomaly-associated inner ear deafness","volume":"7","author":"Schrott\n\u00a0\nA","year":"1987"},{"key":"CIT0065","series-title":"Development","first-page":"453","article-title":"Another role for melanocytes: their importance for normal stria vascularis development in the mammalian inner ear","volume":"107","author":"Steel\n\u00a0\nKP","year":"1989"},{"issue":"1","key":"CIT0066","series-title":"Ophthalmology","first-page":"109","article-title":"Choroidal vitiligo masquerading as large choroidal nevus: a report of four cases","volume":"117","author":"Shields\n\u00a0\nCL","year":"2010"},{"key":"CIT0067","series-title":"J Am Acad Dermatol","first-page":"528","article-title":"The prevalence of vitiligo and poliosis in patients with uveitis","volume":"4","author":"Nordlund\n\u00a0\nJJ","year":"1981"},{"key":"CIT0068","series-title":"Am J Ophthalmol","first-page":"339","article-title":"Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: consideration on the different disease categories","volume":"147","author":"da Silva\n\u00a0\nFT","year":"2009"},{"key":"CIT0069","series-title":"Int J Dermatol","first-page":"829","article-title":"Interferon induced vitiligo in hepatitis C patients: a case series","volume":"49","author":"Hamadah\n\u00a0\nI","year":"2010"},{"key":"CIT0070","series-title":"Skinmed","first-page":"50","article-title":"Segmental vitiligo and hair curling after interferon alpha and ribavirin treatment for hepatitis C","volume":"5","author":"Tinio\n\u00a0\nP","year":"2006"},{"key":"CIT0071","series-title":"J Hepatol","first-page":"38","article-title":"A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alpha interferon","volume":"24","author":"Fattovich\n\u00a0\nC","year":"1996"},{"key":"CIT0072","series-title":"Am J Gastenterol","first-page":"1176","article-title":"Canities and vitiligo complicating interferon therapy for hepatitis C","volume":"90","author":"Brenstien\n\u00a0\nD","year":"1995"},{"key":"CIT0073","series-title":"Adv Ther","first-page":"139","article-title":"Vitiligo associated with pegylated interferon and ribavirin treatment of patients with chronic hepatitis C: a case report","volume":"23","author":"Tomasiewicz\n\u00a0\nK","year":"2006"},{"key":"CIT0074","series-title":"Gasterol Hepatol","first-page":"362","article-title":"Vitiligo and alopecia in patients with chronic hepatitis C treated with alpha interferon associated or not with ribavirin","volume":"23","author":"Primo\n\u00a0\nJ","year":"2000"},{"key":"CIT0075","series-title":"Dermatology","first-page":"65","article-title":"Interferon induced vitiligo in a patient with chronic hepatitis C infection","volume":"193","author":"Simsek\n\u00a0\nH","year":"1996"},{"issue":"4","key":"CIT0076","series-title":"Clin Exp Dermatol","first-page":"503","article-title":"Vitiligo occurring at site of interferon \u03b1 2b injection in a patient with chronic viral hepatitis C: a case report","volume":"33","author":"Anbar\n\u00a0\nTS","year":"2008"},{"key":"CIT0077","series-title":"Case Rep Dermatol","first-page":"156","article-title":"Vitiligo at injection site of PEG-IFN \u03b1 2a in two patients with chronic hepatitis C: case report and literature review","volume":"2","author":"Ayra\n\u00a0\nV","year":"2010"},{"issue":"6","key":"CIT0078","series-title":"J Am Acad Dermatol","first-page":"937","article-title":"A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris","volume":"62","author":"Silverberg\n\u00a0\nJI","year":"2010"},{"issue":"4","key":"CIT0079","series-title":"Curr Opion Pediatr","first-page":"445","article-title":"Update on childhood vitiligo","volume":"22","author":"Silverberg\n\u00a0\nNB","year":"2010"},{"key":"CIT0080","series-title":"Br J Dermatol","first-page":"5","article-title":"Guidelines for the management of vitiligo: the European Dermatology Forum consensus","volume":"168","author":"Taieb\n\u00a0\nA","year":"2012"},{"key":"CIT0081","series-title":"Br J Dermatol","first-page":"1051","article-title":"Guideline for the diagnosis and management of vitiligo","volume":"159","author":"Gawkrodger\n\u00a0\nDJ","year":"2008"},{"key":"CIT0082","series-title":"Arch Dermatol","first-page":"1532","article-title":"Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature","volume":"134","author":"Njoo\n\u00a0\nMD","year":"1998"},{"key":"CIT0083","series-title":"Arch Dermatol","first-page":"1061","article-title":"Left-right comparison study of the combination of fluticasone propionate and UV-A vs either fluticasone or UV-A alone for the long-term treatment of vitiligo","volume":"135","author":"Westerhof\n\u00a0\nW","year":"1999"},{"key":"CIT0084","series-title":"Arch Dermatol","first-page":"631","article-title":"Vitiligo treated with topical clobetasol propionate","volume":"120","author":"Kumari\n\u00a0\nJ","year":"1984"},{"key":"CIT0085","series-title":"Clin Dermatol","first-page":"296","article-title":"The treatment of hypopigmentation in children","volume":"21","author":"Schaffer\n\u00a0\nJV","year":"2003"},{"key":"CIT0086","series-title":"J Am Acad Dermatol","first-page":"964","article-title":"Vitiligo treated with topical corticosteroids: children with head and neck involvement respond well","volume":"46","author":"Cockayne\n\u00a0\nSE","year":"2002"},{"key":"CIT0087","series-title":"Arch Dermatol","first-page":"581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs clobetasol 0.05% for the treatment of childhood vitiligo","volume":"139","author":"Lepe\n\u00a0\nV","year":"2003"},{"key":"CIT0088","series-title":"Eur J Dermatol","first-page":"88","article-title":"Topical 0.05% clobetasol propionate vs 1% pimecrolimus oint in vitiligo","volume":"15","author":"Coskun\n\u00a0\nB","year":"2005"},{"key":"CIT0089","series-title":"J Am Acad Dermatol","first-page":"236","article-title":"High potency steroid use in children with vitiligo: a retrospective study","volume":"56","author":"Kwinter\n\u00a0\nJ","year":"2007"},{"key":"CIT0090","series-title":"J Am Acad Dermatol","first-page":"789","article-title":"Topical tacrolimus for repigmentation of vitiligo","volume":"47","author":"Grimes\n\u00a0\nPE","year":"2002"},{"issue":"5","key":"CIT0091","series-title":"J Pediatr","first-page":"s166","article-title":"Calcineurin inhibitors in the treatment of allergic dermatitis","volume":"82","author":"Castro\n\u00a0\nAP","year":"2006"},{"key":"CIT0092","series-title":"Br J Dermatol","first-page":"490","article-title":"FK506 (tacrolimus) and endothelin combined treatment induce mobility of melanoblasts: new insight into follicular vitiligo repigmentation induced by topical tacrolimus in sun-exposed skin","volume":"164","author":"Lan\n\u00a0\nCCE","year":"2011"},{"key":"CIT0093","series-title":"J Dtsh Dermatol Ges","first-page":"942","article-title":"Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of randomized, double-blind, vehicle-controlled study","volume":"4","author":"Dawid\n\u00a0\nM","year":"2006"},{"key":"CIT0094","series-title":"Int J Dermatol","first-page":"986","article-title":"Two therapeutic challenges: periocular and genital vitiligo in children unsuccessfully treated with pimecrolimus cream","volume":"46","author":"Souze Leite\n\u00a0\nRM","year":"2007"},{"key":"CIT0095","series-title":"Arch Dermatol","first-page":"252","article-title":"Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure","volume":"142","author":"Ostavari\n\u00a0\nN","year":"2006"},{"key":"CIT0096","series-title":"Arch Dermatol","first-page":"1065","article-title":"Topical tacrolimus and 308-excimer laser: a synergistic combination for the treatment of vitiligo","volume":"140","author":"Passeron\n\u00a0\nT","year":"2004"},{"key":"CIT0097","series-title":"Acta Dermatol Venereol","first-page":"474","article-title":"Occlusive treatment enhances the efficacy of tacrolimus 0.1% oint in adult patients with vitiligo: results of placebo-controlled 12-months prospective study","volume":"88","author":"Hartmann\n\u00a0\nA","year":"2008"},{"key":"CIT0098","series-title":"J Deutschen Dermat Ges","first-page":"383","article-title":"repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion","volume":"6","author":"Hartmann\n\u00a0\nA","year":"2008"},{"key":"CIT0099","series-title":"Eur J Dermatol","first-page":"588","article-title":"An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo","volume":"19","author":"Stinco\n\u00a0\nG","year":"2009"},{"key":"CIT0100","series-title":"Br J Dermatol","first-page":"931","article-title":"Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy","volume":"159","author":"Hearn\n\u00a0\nRM","year":"2008"},{"key":"CIT0101","series-title":"J Eur Acad Dermatol Venereol","first-page":"638","article-title":"Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study","volume":"21","author":"Bhatnagar\n\u00a0\nA","year":"2007"},{"key":"CIT0102","series-title":"Photodermatol Photoimmunol Photomed","first-page":"6","article-title":"Narrow band UVB 311 nm in the treatment of vitiligo: two right-left comparison studies","volume":"22","author":"El Mofty\n\u00a0\nM","year":"2001"},{"key":"CIT0103","series-title":"Photodermatol Photoimmunol Photomed","first-page":"159","article-title":"PUVA and PUVB in vitiligo-are they equally effective?","volume":"17","author":"Mofty\n\u00a0\nME","year":"2001"},{"key":"CIT0104","unstructured":"US Food and Drug Administration web site. Available from: www.fda.gov\n\n."},{"key":"CIT0105","series-title":"Br J Dermatol","first-page":"1186","article-title":"Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck","volume":"159","author":"Sassi\n\u00a0\nF","year":"2008"},{"key":"CIT0106","series-title":"Dermatol Surg","first-page":"130","article-title":"Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study","volume":"30","author":"Kawalek\n\u00a0\nAZ","year":"2004"},{"key":"CIT0107","series-title":"J Eur Acad Dermatol Venereol","first-page":"504","article-title":"Combination of 308-nm xenon excimer laser and topical calcipotriol in vitiligo","volume":"21","author":"Goldinger\n\u00a0\nSM","year":"2007"},{"key":"CIT0108","series-title":"Photodermatol Photoimmunol Photomed","first-page":"310","article-title":"Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo","volume":"22","author":"Lu-yan\n\u00a0\nT","year":"2006"},{"issue":"suppl 1","key":"CIT0109","series-title":"Dermatol Ther","first-page":"s20","article-title":"Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects","volume":"21","author":"Lotti\n\u00a0\nT","year":"2008"},{"key":"CIT0110","series-title":"Kaohsiung J Med Sci","first-page":"180","article-title":"Low-energy helium-neon laser therapy induces repigmentation and improves the abnormalities of cutaneous microcirculation in segmental-type vitiligo lesions","volume":"24","author":"Wu\n\u00a0\nCS","year":"2008"},{"key":"CIT0111","series-title":"J Invest Dermatol","first-page":"2119","article-title":"Low-energy helium-neon laser induces locomotion of immature melanoblasts and promotes melanogenesis of the more differentiated melanoblasts: recapitulation of vitiligo repigmentation in vitro","volume":"126","author":"Lan\n\u00a0\nCC","year":"2006"},{"key":"CIT0112","series-title":"J Invest Dermatol","first-page":"56","article-title":"Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo","volume":"120","author":"Yu\n\u00a0\nHS","year":"2003"},{"key":"CIT0113","series-title":"Indian J Dermatol Venereol Leprol","first-page":"18","article-title":"Evaluation of five different regimes for the treatment of vitiligo","volume":"55","author":"Pasricha\n\u00a0\nJS","year":"1989"},{"key":"CIT0114","series-title":"Int J Dermatol","first-page":"753","article-title":"Oral mini-pulse therapy with betametha- sone in vitiligo patients having extensive or fast-spreading disease","volume":"32","author":"Pasricha\n\u00a0\nJS","year":"1993"},{"key":"CIT0115","series-title":"J Am Acad Dermatol","first-page":"814","article-title":"Oral dexamethasone pulse treatment for vitiligo","volume":"44","author":"Radakovic-Fijan\n\u00a0\nS","year":"2001"},{"key":"CIT0116","series-title":"Int J Dermatol","first-page":"546","article-title":"The efficacy of low-dose oral corticosteroids in the treatment of vitiligo","volume":"38","author":"Kim\n\u00a0\nSM","year":"1999"},{"key":"CIT0117","series-title":"Indian J Dermatol Venereol Leprol","first-page":"357","article-title":"An open labeled, comparative clinical study on ef?cacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad\/narrow band UVB phototherapy in progressive vitiligo","volume":"74","author":"Rath\n\u00a0\nN","year":"2008"},{"key":"CIT0118","series-title":"Pigment Cell Res","first-page":"406","article-title":"A review and new hypothesis for non-immunological pathogenetic mechanisms in vitiligo","volume":"19","author":"Dell'Anna\n\u00a0\nML","year":"2006"},{"key":"CIT0119","series-title":"Clin Exp Dermatol","first-page":"285","article-title":"Effectiveness of oral ginkgo biloba in treating limited, slowly spreading vitiligo","volume":"28","author":"Prasad\n\u00a0\nD","year":"2003"},{"key":"CIT0120","series-title":"Clin Exp Dermatol","first-page":"631","article-title":"Antioxidant and narrow band-UVB in the treatment of vitiligo: a double-blind placebo-controlled trial","volume":"32","author":"Dell'Anna\n\u00a0\nML","year":"2007"},{"key":"CIT0121","series-title":"J Eur Acad Dermato Venereol","first-page":"942","article-title":"Treatment of vitiligo vulgaris with narrow-band UVB and oral polypodium leucotomos extract: a randomized double-blind placebo-controlled study","volume":"21","author":"Middelkamp-Hup\n\u00a0\nMA","year":"2007"},{"key":"CIT0122","series-title":"Dermatology","first-page":"223","article-title":"Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients","volume":"190","author":"Schallreuter\n\u00a0\nKU","year":"1995"},{"key":"CIT0123","series-title":"Int J Dermatol","first-page":"482","article-title":"Rapid initiation of repigmentation in vitiligo with dead sea climatotherapy in combination with pseudocatalase (PC-KUS)","volume":"41","author":"Schallreuter\n\u00a0\nKU","year":"2002"},{"key":"CIT0124","series-title":"J Eur Acad Dermato Venereol","first-page":"1359","article-title":"A double-blind, randomized trial of 0.05% betamethasone vs topical catalase\/dismutase superoxide in vitiligo","volume":"22","author":"Sanclemente\n\u00a0\nG","year":"2008"},{"key":"CIT0125","series-title":"Eur J Dermatol","first-page":"341","article-title":"Comparison of the efficacy of narrow band ultraviolet B plus topical catalase-superoxide dismutase treatment in vitiligo patients","volume":"19","author":"Yuskel\n\u00a0\nEP","year":"2009"},{"key":"CIT0126","series-title":"Clin Exp Dermatol","first-page":"641","article-title":"Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-center study","volume":"27","author":"Patel\n\u00a0\nDC","year":"2002"},{"key":"CIT0127","series-title":"Dermatol Sur","first-page":"855","article-title":"Epidermal grafting after chemical ablation in the treatment of vitiligo","volume":"27","author":"Kim\n\u00a0\nCY","year":"2001"},{"issue":"306","key":"CIT0128","series-title":"Int J Dermatol","first-page":"9","article-title":"Modified technique of suction blistering for epidermal grafting in vitiligo","volume":"38","author":"Gupta\n\u00a0\nS","year":"1999"},{"key":"CIT0129","series-title":"Plast Reconstr Surg","first-page":"1291","article-title":"Carbon dioxide laser resurfacing and thin skin graft in the treatment of \u201cstable and recalcitrant\u201d vitiligo","volume":"111","author":"Acikel\n\u00a0\nC","year":"2003"},{"key":"CIT0130","series-title":"Dermatol Sur","first-page":"295","article-title":"Vitiligo: repigmentation with dermabrasion and thin split-thickness skin graft","volume":"21","author":"Agrawal\n\u00a0\nK","year":"1995"},{"key":"CIT0131","series-title":"Int J Dermatol","first-page":"135","article-title":"Comparison of two surigal approaches for treating vitiligo: a preliminary study","volume":"41","author":"Ozdemir\n\u00a0\nM","year":"2002"},{"key":"CIT0132","series-title":"Ann Acad Med Singapore","first-page":"824","article-title":"Repigmentation of vitiligo with autologous blister-induced epidermal graft","volume":"28","author":"Lim\n\u00a0\nJT","year":"1992"},{"key":"CIT0133","series-title":"J Cosm Dermatol","first-page":"119","article-title":"Epithelial grafting for vitiligo requires ultraviolet A phototherapy to increase success rate","volume":"6","author":"Awad\n\u00a0\nSS","year":"2007"},{"key":"CIT0134","series-title":"Dermatology","first-page":"133","article-title":"Treatment of stable and recalcitrant vitiligo by autologous miniature punch grafting: a prospective study of 1,000 patients","volume":"198","author":"Malakar\n\u00a0\nS","year":"1999"},{"key":"CIT0135","series-title":"Int J Dermatol","first-page":"649","article-title":"Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)\u2014a prospective study","volume":"45","author":"Lahiri\n\u00a0\nK","year":"2006"},{"key":"CIT0136","series-title":"Indian J Dermatol Venereol Leprol","first-page":"393","article-title":"A study of autologous melanocyte transfer in treatment of stable vitiligo","volume":"71","author":"Pandya\n\u00a0\nV","year":"2005"},{"key":"CIT0137","series-title":"Arch Dermatol","first-page":"1203","article-title":"Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repig- menting vitiligo","volume":"140","author":"van Geel\n\u00a0\nN","year":"2004"},{"key":"CIT0138","series-title":"Int J Dermatol","first-page":"841","article-title":"Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation","volume":"44","author":"Mulekar\n\u00a0\nSV","year":"2005"},{"key":"CIT0139","series-title":"Dermatol Surg","first-page":"436","article-title":"Comparison of minipunch grafting versus split-skin grafting in chronic stable vitiligo","volume":"31","author":"Khandpur\n\u00a0\nS","year":"2005"},{"key":"CIT0140","series-title":"Dermatol Surg","first-page":"49","article-title":"A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo","volume":"30","author":"Barman\n\u00a0\nKD","year":"2004"},{"key":"CIT0141","series-title":"Int J Dermatol","first-page":"649","article-title":"Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)\u2014a prospective study","volume":"45","author":"Lahiri\n\u00a0\nK","year":"2006"},{"key":"CIT0142","series-title":"J Cos- met Dermatol","first-page":"72","article-title":"Camou?age for patients with vitiligo vulgaris improved their quality of life","volume":"9","author":"Tanioka\n\u00a0\nM","year":"2010"},{"key":"CIT0143","series-title":"\u2018La Voce dei Pazienti\u2019. Evidence Based Dermatology","author":"DePase\n\u00a0\nA","year":"2003"},{"key":"CIT0144","series-title":"Dermatology","first-page":"279","article-title":"Quality of life and stig- matization pro?le in a cohort of vitiligo patients and effect of the use of camou?age","volume":"210","author":"Ongenae\n\u00a0\nK","year":"2005"},{"key":"CIT0145","series-title":"Clin Exp Dermatol","first-page":"393","article-title":"The hidden face of dermatology","volume":"18","author":"Savin\n\u00a0\nJ","year":"1993"},{"key":"CIT0146","series-title":"Clin Dermatol","first-page":"30","article-title":"Permanent makeup: indications and complications","volume":"26","author":"De Cuyper\n\u00a0\nC","year":"2008"},{"key":"CIT0147","series-title":"Br J Dermatol","first-page":"669","article-title":"Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature","volume":"97","author":"Mosher\n\u00a0\nDB","year":"1977"},{"key":"CIT0148","series-title":"J Am Acad Dermatol","first-page":"760","article-title":"Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q- switched ruby laser","volume":"42","author":"Njoo\n\u00a0\nMD","year":"2000"},{"key":"CIT0149","series-title":"Dermatol Surg","first-page":"1043","article-title":"Use of the Q-switched 755-nm alexandrite laser to treat recalcitrant pigment after depigmentation therapy for vitiligo","volume":"30","author":"Rao\n\u00a0\nJ","year":"2004"},{"key":"CIT0150","series-title":"J Am Acad Dermatol","first-page":"411","article-title":"The burden of vitiligo: patient characteristics associated with quality of life","volume":"61","author":"Linthorst Homan\n\u00a0\nMW","year":"2009"},{"key":"CIT0151","series-title":"Br J Dermatol","first-page":"481","article-title":"Vitiligo linked to stigmatization in British South Asian women: a qualitative study of the experiences of living with vitiligo","volume":"163","author":"Thompson\n\u00a0\nAR","year":"2010"},{"key":"CIT0152","series-title":"Vitiligo","first-page":"433","article-title":"Psychological interventions","author":"Kostoupolou\n\u00a0\nP","year":"2009"},{"key":"CIT0153","series-title":"Br J Dermatol","first-page":"128","article-title":"Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral center","volume":"161","author":"Kostopolou\n\u00a0\nP","year":"2009"},{"key":"CIT0154","series-title":"Clin Exp Dermatol","first-page":"736","article-title":"Vitiligo is more than skin deep: a survey of members of the Vitiligo Society","volume":"35","author":"Talsania\n\u00a0\nN","year":"2009"},{"key":"CIT0155","series-title":"Int J Dermatol","first-page":"992","article-title":"Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo","volume":"45","author":"Birol\n\u00a0\nA","year":"2006"},{"key":"CIT0156","series-title":"Dermatology","first-page":"234","article-title":"Vitiligo improvement in a patient with ankylosing spondylitis treated with infliximab","volume":"216","author":"Simon\n\u00a0\nJA","year":"2008"},{"issue":"2 Suppl 1","key":"CIT0157","series-title":"J Am Acad Dermatol","first-page":"S57","article-title":"Repigmentation of vitiligo during eflizumab","volume":"59","author":"Wakkee\n\u00a0\nM","year":"2008"},{"key":"CIT0158","series-title":"J Cutan Med Surg","first-page":"172","article-title":"Familial and colocalized psoriasis and vitiligo responding to alefacept","volume":"13","author":"Al-Mutairi\n\u00a0\nN","year":"2009"},{"key":"CIT0159","series-title":"J Dermatol Treat","first-page":"151","article-title":"The Efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients","volume":"17","author":"Radmanesh\n\u00a0\nM","year":"2006"},{"issue":"3","key":"CIT0160","series-title":"Dermatol Online J","first-page":"30","article-title":"Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir","volume":"11","author":"Dogra\n\u00a0\nS","year":"2005"},{"key":"CIT0161","series-title":"J Invest Dermatol","first-page":"758","article-title":"Enhanced integumental and ocular amelanosis following the termination of cyclosporine administration","volume":"88","author":"Pardue\n\u00a0\nSL","year":"1987"},{"issue":"2","key":"CIT0162","series-title":"Skin Ther Letter","first-page":"1","article-title":"Update on new and emerging options for the treatment of vitiligo","volume":"13","author":"Mahmoud\n\u00a0\nCL","year":"2008"},{"issue":"8","key":"CIT0163","series-title":"Int J Dermatol","first-page":"875","article-title":"evaluation of the therapeutic efficacy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream, and dermabrasion combined with topical Placentrex\u00ae gel in localized stable vitiligo","volume":"46","author":"Sethi\n\u00a0\nRR","year":"2007"},{"key":"CIT0164","series-title":"Cochrane Database Syst Rev","first-page":"1","article-title":"for vitiligo","volume":"20","author":"Whitton\n\u00a0\nJ","year":"2010"},{"key":"CIT0001","series-title":"Taiieb A: Vitiligo","author":"Picardo\n\u00a0\nM","year":"2010"},{"key":"CIT0002","series-title":"Fitzpatric's Dermatology in General Medicine","article-title":"Norris DA: Vitiligo","author":"Birlea\n\u00a0\nSA","year":"in press"},{"key":"CIT0003","series-title":"Pigment Cell Res","first-page":"208","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their relatives","volume":"16","author":"Alkhateeb\n\u00a0\nA","year":"2003"},{"key":"CIT0004","series-title":"Int J Dermatol","first-page":"328","article-title":"Case detection rates of vitiligo by gender and age","volume":"48","author":"Kyriakis\n\u00a0\nKP","year":"2009"},{"key":"CIT0005","series-title":"J Am Acad Dermatol","first-page":"473","article-title":"Vitiligo: A comprehensive overview Part 1. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work up","volume":"65","author":"Alikhan\n\u00a0\nA","year":"2011"},{"key":"CIT0006","series-title":"The Pigmentry System","first-page":"513","article-title":"Vitiligo Vulgaris","author":"Nordlund\n\u00a0\nJJ","year":"1993"},{"key":"CIT0007","series-title":"Vitiligo","author":"Hann\n\u00a0\nS-K","year":"2000"},{"key":"CIT0008","series-title":"J Dermatol Science","first-page":"3","article-title":"The genetics of generalized vitiligo and associated autoimmune diseases","volume":"41","author":"Spritz\n\u00a0\nRA","year":"2006"},{"key":"CIT0009","series-title":"Arch Dermatol","first-page":"1062","article-title":"Characteristics of patients with universal vitiligo and health related quality of life","volume":"144","author":"Linthorst Homan\n\u00a0\nMW","year":"2008"},{"key":"CIT0010","series-title":"J Am Acad Dermatol","first-page":"621","article-title":"An epidemiologic case-control study in a population with vitiligo","volume":"33","author":"Barona\n\u00a0\nMI","year":"1995"},{"key":"CIT0011","series-title":"Fitzpatrick's dermatology in general medicine","first-page":"72","article-title":"Vitiligo","author":"Halder\n\u00a0\nRM","year":"2008"},{"key":"CIT0012","series-title":"Vitiligo","first-page":"155","article-title":"Genetics","author":"Spritz\n\u00a0\nRA","year":"2010"},{"key":"CIT0013","series-title":"Pigment Cell Res","first-page":"208","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb\n\u00a0\nA","year":"2003"},{"key":"CIT0014","series-title":"J Am Acad Dermatol","first-page":"671","article-title":"Segmental vitiligo: clinical findings in 208 patients","volume":"35","author":"Hann\n\u00a0\nSK","year":"1996"},{"key":"CIT0015","series-title":"Pigment Cell Res","first-page":"322","article-title":"A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?","volume":"16","author":"Gauthier\n\u00a0\nY","year":"2003"},{"key":"CIT0016","series-title":"Exp Dermatol","first-page":"145","article-title":"Review of the etiopathomechanism of vitiligo: a convergence theory","volume":"2","author":"Le Poole\n\u00a0\nIC","year":"1993"},{"key":"CIT0017","series-title":"J Am Acad Dermatol","first-page":"52","article-title":"Topical tacrolimus therapy in vitiligo: Therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","volume":"51","author":"Grimes\n\u00a0\nPE","year":"2004"},{"key":"CIT0018","series-title":"Br J Dermatol","first-page":"1275","article-title":"Gene expression study of IL10 family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera","volume":"159","author":"R\u00e4step\n\u00a0\nR","year":"2008"},{"key":"CIT0019","series-title":"Human Immunol","first-page":"393","article-title":"The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells","volume":"73","author":"Reimann\n\u00a0\nE","year":"2012"},{"key":"CIT0020","series-title":"J Histochem Cytochem","first-page":"125","article-title":"Melanocyte function and its control by melanocortin peptides","volume":"50","author":"Stimuli\n\u00a0\nM","year":"2002"},{"key":"CIT0021","series-title":"J Lab Clin Med","first-page":"658","article-title":"Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin","volume":"122","author":"Slominski\n\u00a0\nA","year":"1993"},{"key":"CIT0022","series-title":"Peptides","first-page":"813","article-title":"MSH peptides are present in mammalian skin","volume":"4","author":"Thody\n\u00a0\nAJ","year":"1983"},{"key":"CIT0023","series-title":"Neuropeptides","first-page":"177","article-title":"Vitiligo patients present lower plasma levels of alpha melanotropin immunoreactivities","volume":"40","author":"Pichler\n\u00a0\nR","year":"2006"},{"key":"CIT0024","series-title":"Ann NY Acad Sci","first-page":"470","article-title":"The expression of alpha-MSH by melanocytes is reduced in vitiligo","volume":"885","author":"Graham\n\u00a0\nA","year":"1999"},{"key":"CIT0025","series-title":"J Dermatol Sci","first-page":"113","article-title":"Gene expression analysis of melanocortin system in vitiligo","volume":"48","author":"Kingo\n\u00a0\nK","year":"2007"},{"key":"CIT0026","series-title":"J Investig Dermatol","first-page":"798","article-title":"Genome wide-association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8","volume":"130","author":"Birlea\n\u00a0\nSA","year":"2010"},{"key":"CIT0027","series-title":"N Engl J Med","first-page":"1686","article-title":"Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo","volume":"362","author":"Jin\n\u00a0\nY","year":"2010"},{"key":"CIT0028","series-title":"Nat Genet","first-page":"576","article-title":"Common variants of FOXP1 are associated with generalized vitiligo","volume":"42","author":"Jin\n\u00a0\nY","year":"2010"},{"key":"CIT0029","series-title":"Nat Genet","first-page":"614","article-title":"Genome wide-association study for vitiligo identifies susceptibility loci at 6q27 and MHC","volume":"42","author":"Quan\n\u00a0\nC","year":"2010"},{"issue":"9","key":"CIT0030","series-title":"J Eur Acad Dermatol Venereol","first-page":"1137","article-title":"A single nucleotide polymorphism rs9468925 of MHC region is associated with clinical features of generalized vitiligo in Chinese Han population","volume":"26","author":"Liu\n\u00a0\nJ","year":"2012"},{"key":"CIT0031","series-title":"Genome Med","first-page":"78","article-title":"The genetics of generalized vitiligo: autoimmune pathways and inverse relation with malignant melanoma","volume":"2","author":"Spritz\n\u00a0\nLA","year":"2010"},{"key":"CIT0032","series-title":"J Invest Dermatol","first-page":"371","article-title":"Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, AND TSLP","volume":"131","author":"Birlea\n\u00a0\nSA","year":"2011"},{"issue":"8","key":"CIT0033","series-title":"Arch Dermatol Res","first-page":"631","article-title":"Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs","volume":"302","author":"Alkhateeb\n\u00a0\nA","year":"2010"},{"key":"CIT0034","series-title":"J Invest Dermatol","first-page":"774","article-title":"Fine-mapping of vitiligo susceptibility loci on chromosome 7 and 9 and interactions with NLRP1 (NALP1)","volume":"130","author":"Jin\n\u00a0\nY","year":"2010"},{"key":"CIT0035","series-title":"Pigment Cell Res","first-page":"90","article-title":"Evidence of an autoimmune pathogenesis of vitiligo","volume":"16","author":"Ongenae\n\u00a0\nK","year":"2003"},{"key":"CIT0036","series-title":"Autoimmun Rev","first-page":"762","article-title":"Immunopathogenesis of vitiligo","volume":"10","author":"Sandoval-Cruz\n\u00a0\nM","year":"2011"},{"key":"CIT0037","series-title":"J Autoimmun","first-page":"63","article-title":"Pathophysiology and genetics of vitiligo","volume":"25","author":"Passeron\n\u00a0\nT","year":"2005"},{"issue":"7","key":"CIT0038","series-title":"Autoimmun Rev","first-page":"516","article-title":"Current remedies for vitiligo","volume":"9","author":"Abu Tahir\n\u00a0\nM","year":"2010"},{"key":"CIT0039","series-title":"Pak J Pharm Sci","first-page":"96","article-title":"Immunoglobulin levels in vitiligo patients","volume":"23","author":"Ali\n\u00a0\nR","year":"2010"},{"key":"CIT0040","series-title":"J Invest Dermatol","first-page":"969","article-title":"IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule 1expression and increased IL-8 release by melanocytes","volume":"115","author":"Li\n\u00a0\nYL","year":"2000"},{"key":"CIT0041","series-title":"Autoimmun Rev","first-page":"138","article-title":"Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo","volume":"3","author":"Kemp\n\u00a0\nEH","year":"2007"},{"key":"CIT0042","series-title":"Medical Hypotheses","first-page":"67","article-title":"The Double Strike hypothesis of the vitiligo pathomechanism: New approaches to vitiligo and melanoma","volume":"74","author":"Michelsen\n\u00a0\nD","year":"2010"},{"key":"CIT0043","series-title":"Pigment Cell Melanoma Res","first-page":"276","article-title":"Reduced skin homing by functional Treg in vitiligo","volume":"23","author":"Klarquist\n\u00a0\nJ","year":"2010"},{"key":"CIT0044","series-title":"Pigment Cell Melanoma Res","first-page":"375","article-title":"First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi","volume":"23","author":"van Geel\n\u00a0\nNAC","year":"2010"},{"key":"CIT0045","series-title":"PloS ONE","first-page":"1","article-title":"Global Activation of CD8+ Cytotoxic T Lymphocytes Correlates with an Impairment in Regulatory T Cells in Patients with Generalized Vitiligo","volume":"7","author":"Lili\n\u00a0\nY","year":"2012"},{"key":"CIT0046","series-title":"Pigment Cell Melanoma Res","first-page":"602","article-title":"Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells","volume":"25","author":"Zhou\n\u00a0\nL","year":"2012"},{"key":"CIT0047","series-title":"Vitiligo","article-title":"Autocytotoxic hypothesis for the destruction of melanocytes as the cause of vitiligo","author":"Hann\n\u00a0\nSK","year":"2000"},{"key":"CIT0048","series-title":"J Invest Dermatol","first-page":"1081","article-title":"Low catalase level in the epidermis in patients with vitiligo","volume":"97","author":"Schallreuter\n\u00a0\nKU","year":"1991"},{"key":"CIT0049","series-title":"J Inest Dermatol Sym Proc","first-page":"91","article-title":"In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation IN THE EPIDERMIS of patients with vitiligo and its successful removal by UVB-activated pseudocatalase","volume":"4","author":"Schallreuter\n\u00a0\nKU","year":"1999"},{"key":"CIT0050","series-title":"Pigment Cell Res","first-page":"62","article-title":"Genetic association of the catalase gene (CAT) with vitiligo susceptibility","volume":"15","author":"Casp\n\u00a0\nCB","year":"2002"},{"key":"CIT0051","series-title":"Clinical Science","first-page":"99","article-title":"Vitiligo, reactive oxygen species and T-cells","volume":"120","author":"Glassman\n\u00a0\nSJ","year":"2011"},{"key":"CIT0052","series-title":"Science","first-page":"1444","article-title":"Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin","volume":"263","author":"Schallreuter\n\u00a0\nKU","year":"1994"},{"key":"CIT0053","series-title":"Biochem Biophys Res Commun","first-page":"43","article-title":"Cytotoxicity of 6-biopterin to human melanocytes","volume":"204","author":"Schallreuter\n\u00a0\nKU","year":"1994"},{"key":"CIT0054","series-title":"Br J Dermatol","first-page":"171","article-title":"Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion","volume":"137","author":"Le Poole\n\u00a0\nIC","year":"1997"},{"key":"CIT0055","series-title":"J Pathol","first-page":"465","article-title":"Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: rple od SCF\/KIT interactions and the downstream effector MITF-M","volume":"202","author":"Kitamura\n\u00a0\nR","year":"2004"},{"key":"CIT0056","series-title":"J Invest Dermatol","first-page":"976","article-title":"Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may lead to may cause passive melanocyte death in vitiligo","volume":"123","author":"Lee\n\u00a0\nAY","year":"2005"},{"key":"CIT0057","series-title":"Pigment Cell Melanoma Res","first-page":"E1","article-title":"Vitiligo Global Issue Consensus Conference Panelists. Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine\n\u00a0\nK","year":"2012"},{"key":"CIT0058","series-title":"J Am Acad Dermatol","first-page":"945","article-title":"Segmental and nonsegmental childhood vitiligo have distinct clinical characteristics: A prospective observational study","volume":"62","author":"Mazereeuw-Hautier\n\u00a0\nJ","year":"2010"},{"key":"CIT0059","series-title":"J Eur Acad Dermatol Venereol","first-page":"673","article-title":"Different phenotypes of segmental vitiligo based on a clinical observational study","volume":"25","author":"van Geel\n\u00a0\nN","year":"2011"},{"key":"CIT0060","series-title":"Eur Acad Dermatol Venereol","first-page":"105","article-title":"Vitiligo and autoimmunity: an epidemiological study in a representative sample of young Italian males","volume":"1","author":"Ingordo\n\u00a0\nV","year":"2011"},{"key":"CIT0061","series-title":"J Eur Acad Dermatol Venereol","first-page":"1144","article-title":"Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey","volume":"24","author":"Akay\n\u00a0\nBN","year":"2010"},{"key":"CIT0062","series-title":"Otolaryngol Head Neck Surg","first-page":"409","article-title":"Audiological and transient evoked otoacoustic emission findings in patients with vitiligo","volume":"142","author":"Aslan\n\u00a0\nS","year":"2010"},{"key":"CIT0063","series-title":"Dermatology","first-page":"901","article-title":"Melanocyte biology","author":"Bolognia\n\u00a0\nJL","year":"2008"},{"key":"CIT0064","series-title":"Acta Otolaryngol","first-page":"17","article-title":"Pigment anomaly-associated inner ear deafness","volume":"7","author":"Schrott\n\u00a0\nA","year":"1987"},{"key":"CIT0065","series-title":"Development","first-page":"453","article-title":"Another role for melanocytes: their importance for normal stria vascularis development in the mammalian inner ear","volume":"107","author":"Steel\n\u00a0\nKP","year":"1989"},{"issue":"1","key":"CIT0066","series-title":"Ophthalmology","first-page":"109","article-title":"Choroidal vitiligo masquerading as large choroidal nevus: a report of four cases","volume":"117","author":"Shields\n\u00a0\nCL","year":"2010"},{"key":"CIT0067","series-title":"J Am Acad Dermatol","first-page":"528","article-title":"The prevalence of vitiligo and poliosis in patients with uveitis","volume":"4","author":"Nordlund\n\u00a0\nJJ","year":"1981"},{"key":"CIT0068","series-title":"Am J Ophthalmol","first-page":"339","article-title":"Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: consideration on the different disease categories","volume":"147","author":"da Silva\n\u00a0\nFT","year":"2009"},{"key":"CIT0069","series-title":"Int J Dermatol","first-page":"829","article-title":"Interferon induced vitiligo in hepatitis C patients: a case series","volume":"49","author":"Hamadah\n\u00a0\nI","year":"2010"},{"key":"CIT0070","series-title":"Skinmed","first-page":"50","article-title":"Segmental vitiligo and hair curling after interferon alpha and ribavirin treatment for hepatitis C","volume":"5","author":"Tinio\n\u00a0\nP","year":"2006"},{"key":"CIT0071","series-title":"J Hepatol","first-page":"38","article-title":"A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alpha interferon","volume":"24","author":"Fattovich\n\u00a0\nC","year":"1996"},{"key":"CIT0072","series-title":"Am J Gastenterol","first-page":"1176","article-title":"Canities and vitiligo complicating interferon therapy for hepatitis C","volume":"90","author":"Brenstien\n\u00a0\nD","year":"1995"},{"key":"CIT0073","series-title":"Adv Ther","first-page":"139","article-title":"Vitiligo associated with pegylated interferon and ribavirin treatment of patients with chronic hepatitis C: a case report","volume":"23","author":"Tomasiewicz\n\u00a0\nK","year":"2006"},{"key":"CIT0074","series-title":"Gasterol Hepatol","first-page":"362","article-title":"Vitiligo and alopecia in patients with chronic hepatitis C treated with alpha interferon associated or not with ribavirin","volume":"23","author":"Primo\n\u00a0\nJ","year":"2000"},{"key":"CIT0075","series-title":"Dermatology","first-page":"65","article-title":"Interferon induced vitiligo in a patient with chronic hepatitis C infection","volume":"193","author":"Simsek\n\u00a0\nH","year":"1996"},{"issue":"4","key":"CIT0076","series-title":"Clin Exp Dermatol","first-page":"503","article-title":"Vitiligo occurring at site of interferon \u03b1 2b injection in a patient with chronic viral hepatitis C: a case report","volume":"33","author":"Anbar\n\u00a0\nTS","year":"2008"},{"key":"CIT0077","series-title":"Case Rep Dermatol","first-page":"156","article-title":"Vitiligo at injection site of PEG-IFN \u03b1 2a in two patients with chronic hepatitis C: case report and literature review","volume":"2","author":"Ayra\n\u00a0\nV","year":"2010"},{"issue":"6","key":"CIT0078","series-title":"J Am Acad Dermatol","first-page":"937","article-title":"A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris","volume":"62","author":"Silverberg\n\u00a0\nJI","year":"2010"},{"issue":"4","key":"CIT0079","series-title":"Curr Opion Pediatr","first-page":"445","article-title":"Update on childhood vitiligo","volume":"22","author":"Silverberg\n\u00a0\nNB","year":"2010"},{"key":"CIT0080","series-title":"Br J Dermatol","first-page":"5","article-title":"Guidelines for the management of vitiligo: the European Dermatology Forum consensus","volume":"168","author":"Taieb\n\u00a0\nA","year":"2012"},{"key":"CIT0081","series-title":"Br J Dermatol","first-page":"1051","article-title":"Guideline for the diagnosis and management of vitiligo","volume":"159","author":"Gawkrodger\n\u00a0\nDJ","year":"2008"},{"key":"CIT0082","series-title":"Arch Dermatol","first-page":"1532","article-title":"Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature","volume":"134","author":"Njoo\n\u00a0\nMD","year":"1998"},{"key":"CIT0083","series-title":"Arch Dermatol","first-page":"1061","article-title":"Left-right comparison study of the combination of fluticasone propionate and UV-A vs either fluticasone or UV-A alone for the long-term treatment of vitiligo","volume":"135","author":"Westerhof\n\u00a0\nW","year":"1999"},{"key":"CIT0084","series-title":"Arch Dermatol","first-page":"631","article-title":"Vitiligo treated with topical clobetasol propionate","volume":"120","author":"Kumari\n\u00a0\nJ","year":"1984"},{"key":"CIT0085","series-title":"Clin Dermatol","first-page":"296","article-title":"The treatment of hypopigmentation in children","volume":"21","author":"Schaffer\n\u00a0\nJV","year":"2003"},{"key":"CIT0086","series-title":"J Am Acad Dermatol","first-page":"964","article-title":"Vitiligo treated with topical corticosteroids: children with head and neck involvement respond well","volume":"46","author":"Cockayne\n\u00a0\nSE","year":"2002"},{"key":"CIT0087","series-title":"Arch Dermatol","first-page":"581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs clobetasol 0.05% for the treatment of childhood vitiligo","volume":"139","author":"Lepe\n\u00a0\nV","year":"2003"},{"key":"CIT0088","series-title":"Eur J Dermatol","first-page":"88","article-title":"Topical 0.05% clobetasol propionate vs 1% pimecrolimus oint in vitiligo","volume":"15","author":"Coskun\n\u00a0\nB","year":"2005"},{"key":"CIT0089","series-title":"J Am Acad Dermatol","first-page":"236","article-title":"High potency steroid use in children with vitiligo: a retrospective study","volume":"56","author":"Kwinter\n\u00a0\nJ","year":"2007"},{"key":"CIT0090","series-title":"J Am Acad Dermatol","first-page":"789","article-title":"Topical tacrolimus for repigmentation of vitiligo","volume":"47","author":"Grimes\n\u00a0\nPE","year":"2002"},{"issue":"5","key":"CIT0091","series-title":"J Pediatr","first-page":"s166","article-title":"Calcineurin inhibitors in the treatment of allergic dermatitis","volume":"82","author":"Castro\n\u00a0\nAP","year":"2006"},{"key":"CIT0092","series-title":"Br J Dermatol","first-page":"490","article-title":"FK506 (tacrolimus) and endothelin combined treatment induce mobility of melanoblasts: new insight into follicular vitiligo repigmentation induced by topical tacrolimus in sun-exposed skin","volume":"164","author":"Lan\n\u00a0\nCCE","year":"2011"},{"key":"CIT0093","series-title":"J Dtsh Dermatol Ges","first-page":"942","article-title":"Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of randomized, double-blind, vehicle-controlled study","volume":"4","author":"Dawid\n\u00a0\nM","year":"2006"},{"key":"CIT0094","series-title":"Int J Dermatol","first-page":"986","article-title":"Two therapeutic challenges: periocular and genital vitiligo in children unsuccessfully treated with pimecrolimus cream","volume":"46","author":"Souze Leite\n\u00a0\nRM","year":"2007"},{"key":"CIT0095","series-title":"Arch Dermatol","first-page":"252","article-title":"Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure","volume":"142","author":"Ostavari\n\u00a0\nN","year":"2006"},{"key":"CIT0096","series-title":"Arch Dermatol","first-page":"1065","article-title":"Topical tacrolimus and 308-excimer laser: a synergistic combination for the treatment of vitiligo","volume":"140","author":"Passeron\n\u00a0\nT","year":"2004"},{"key":"CIT0097","series-title":"Acta Dermatol Venereol","first-page":"474","article-title":"Occlusive treatment enhances the efficacy of tacrolimus 0.1% oint in adult patients with vitiligo: results of placebo-controlled 12-months prospective study","volume":"88","author":"Hartmann\n\u00a0\nA","year":"2008"},{"key":"CIT0098","series-title":"J Deutschen Dermat Ges","first-page":"383","article-title":"repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion","volume":"6","author":"Hartmann\n\u00a0\nA","year":"2008"},{"key":"CIT0099","series-title":"Eur J Dermatol","first-page":"588","article-title":"An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo","volume":"19","author":"Stinco\n\u00a0\nG","year":"2009"},{"key":"CIT0100","series-title":"Br J Dermatol","first-page":"931","article-title":"Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy","volume":"159","author":"Hearn\n\u00a0\nRM","year":"2008"},{"key":"CIT0101","series-title":"J Eur Acad Dermatol Venereol","first-page":"638","article-title":"Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study","volume":"21","author":"Bhatnagar\n\u00a0\nA","year":"2007"},{"key":"CIT0102","series-title":"Photodermatol Photoimmunol Photomed","first-page":"6","article-title":"Narrow band UVB 311 nm in the treatment of vitiligo: two right-left comparison studies","volume":"22","author":"El Mofty\n\u00a0\nM","year":"2001"},{"key":"CIT0103","series-title":"Photodermatol Photoimmunol Photomed","first-page":"159","article-title":"PUVA and PUVB in vitiligo-are they equally effective?","volume":"17","author":"Mofty\n\u00a0\nME","year":"2001"},{"key":"CIT0104","unstructured":"US Food and Drug Administration web site. Available from: www.fda.gov\n\n."},{"key":"CIT0105","series-title":"Br J Dermatol","first-page":"1186","article-title":"Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck","volume":"159","author":"Sassi\n\u00a0\nF","year":"2008"},{"key":"CIT0106","series-title":"Dermatol Surg","first-page":"130","article-title":"Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study","volume":"30","author":"Kawalek\n\u00a0\nAZ","year":"2004"},{"key":"CIT0107","series-title":"J Eur Acad Dermatol Venereol","first-page":"504","article-title":"Combination of 308-nm xenon excimer laser and topical calcipotriol in vitiligo","volume":"21","author":"Goldinger\n\u00a0\nSM","year":"2007"},{"key":"CIT0108","series-title":"Photodermatol Photoimmunol Photomed","first-page":"310","article-title":"Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo","volume":"22","author":"Lu-yan\n\u00a0\nT","year":"2006"},{"issue":"suppl 1","key":"CIT0109","series-title":"Dermatol Ther","first-page":"s20","article-title":"Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects","volume":"21","author":"Lotti\n\u00a0\nT","year":"2008"},{"key":"CIT0110","series-title":"Kaohsiung J Med Sci","first-page":"180","article-title":"Low-energy helium-neon laser therapy induces repigmentation and improves the abnormalities of cutaneous microcirculation in segmental-type vitiligo lesions","volume":"24","author":"Wu\n\u00a0\nCS","year":"2008"},{"key":"CIT0111","series-title":"J Invest Dermatol","first-page":"2119","article-title":"Low-energy helium-neon laser induces locomotion of immature melanoblasts and promotes melanogenesis of the more differentiated melanoblasts: recapitulation of vitiligo repigmentation in vitro","volume":"126","author":"Lan\n\u00a0\nCC","year":"2006"},{"key":"CIT0112","series-title":"J Invest Dermatol","first-page":"56","article-title":"Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo","volume":"120","author":"Yu\n\u00a0\nHS","year":"2003"},{"key":"CIT0113","series-title":"Indian J Dermatol Venereol Leprol","first-page":"18","article-title":"Evaluation of five different regimes for the treatment of vitiligo","volume":"55","author":"Pasricha\n\u00a0\nJS","year":"1989"},{"key":"CIT0114","series-title":"Int J Dermatol","first-page":"753","article-title":"Oral mini-pulse therapy with betametha- sone in vitiligo patients having extensive or fast-spreading disease","volume":"32","author":"Pasricha\n\u00a0\nJS","year":"1993"},{"key":"CIT0115","series-title":"J Am Acad Dermatol","first-page":"814","article-title":"Oral dexamethasone pulse treatment for vitiligo","volume":"44","author":"Radakovic-Fijan\n\u00a0\nS","year":"2001"},{"key":"CIT0116","series-title":"Int J Dermatol","first-page":"546","article-title":"The efficacy of low-dose oral corticosteroids in the treatment of vitiligo","volume":"38","author":"Kim\n\u00a0\nSM","year":"1999"},{"key":"CIT0117","series-title":"Indian J Dermatol Venereol Leprol","first-page":"357","article-title":"An open labeled, comparative clinical study on ef?cacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad\/narrow band UVB phototherapy in progressive vitiligo","volume":"74","author":"Rath\n\u00a0\nN","year":"2008"},{"key":"CIT0118","series-title":"Pigment Cell Res","first-page":"406","article-title":"A review and new hypothesis for non-immunological pathogenetic mechanisms in vitiligo","volume":"19","author":"Dell'Anna\n\u00a0\nML","year":"2006"},{"key":"CIT0119","series-title":"Clin Exp Dermatol","first-page":"285","article-title":"Effectiveness of oral ginkgo biloba in treating limited, slowly spreading vitiligo","volume":"28","author":"Prasad\n\u00a0\nD","year":"2003"},{"key":"CIT0120","series-title":"Clin Exp Dermatol","first-page":"631","article-title":"Antioxidant and narrow band-UVB in the treatment of vitiligo: a double-blind placebo-controlled trial","volume":"32","author":"Dell'Anna\n\u00a0\nML","year":"2007"},{"key":"CIT0121","series-title":"J Eur Acad Dermato Venereol","first-page":"942","article-title":"Treatment of vitiligo vulgaris with narrow-band UVB and oral polypodium leucotomos extract: a randomized double-blind placebo-controlled study","volume":"21","author":"Middelkamp-Hup\n\u00a0\nMA","year":"2007"},{"key":"CIT0122","series-title":"Dermatology","first-page":"223","article-title":"Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients","volume":"190","author":"Schallreuter\n\u00a0\nKU","year":"1995"},{"key":"CIT0123","series-title":"Int J Dermatol","first-page":"482","article-title":"Rapid initiation of repigmentation in vitiligo with dead sea climatotherapy in combination with pseudocatalase (PC-KUS)","volume":"41","author":"Schallreuter\n\u00a0\nKU","year":"2002"},{"key":"CIT0124","series-title":"J Eur Acad Dermato Venereol","first-page":"1359","article-title":"A double-blind, randomized trial of 0.05% betamethasone vs topical catalase\/dismutase superoxide in vitiligo","volume":"22","author":"Sanclemente\n\u00a0\nG","year":"2008"},{"key":"CIT0125","series-title":"Eur J Dermatol","first-page":"341","article-title":"Comparison of the efficacy of narrow band ultraviolet B plus topical catalase-superoxide dismutase treatment in vitiligo patients","volume":"19","author":"Yuskel\n\u00a0\nEP","year":"2009"},{"key":"CIT0126","series-title":"Clin Exp Dermatol","first-page":"641","article-title":"Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-center study","volume":"27","author":"Patel\n\u00a0\nDC","year":"2002"},{"key":"CIT0127","series-title":"Dermatol Sur","first-page":"855","article-title":"Epidermal grafting after chemical ablation in the treatment of vitiligo","volume":"27","author":"Kim\n\u00a0\nCY","year":"2001"},{"issue":"306","key":"CIT0128","series-title":"Int J Dermatol","first-page":"9","article-title":"Modified technique of suction blistering for epidermal grafting in vitiligo","volume":"38","author":"Gupta\n\u00a0\nS","year":"1999"},{"key":"CIT0129","series-title":"Plast Reconstr Surg","first-page":"1291","article-title":"Carbon dioxide laser resurfacing and thin skin graft in the treatment of \u201cstable and recalcitrant\u201d vitiligo","volume":"111","author":"Acikel\n\u00a0\nC","year":"2003"},{"key":"CIT0130","series-title":"Dermatol Sur","first-page":"295","article-title":"Vitiligo: repigmentation with dermabrasion and thin split-thickness skin graft","volume":"21","author":"Agrawal\n\u00a0\nK","year":"1995"},{"key":"CIT0131","series-title":"Int J Dermatol","first-page":"135","article-title":"Comparison of two surigal approaches for treating vitiligo: a preliminary study","volume":"41","author":"Ozdemir\n\u00a0\nM","year":"2002"},{"key":"CIT0132","series-title":"Ann Acad Med Singapore","first-page":"824","article-title":"Repigmentation of vitiligo with autologous blister-induced epidermal graft","volume":"28","author":"Lim\n\u00a0\nJT","year":"1992"},{"key":"CIT0133","series-title":"J Cosm Dermatol","first-page":"119","article-title":"Epithelial grafting for vitiligo requires ultraviolet A phototherapy to increase success rate","volume":"6","author":"Awad\n\u00a0\nSS","year":"2007"},{"key":"CIT0134","series-title":"Dermatology","first-page":"133","article-title":"Treatment of stable and recalcitrant vitiligo by autologous miniature punch grafting: a prospective study of 1,000 patients","volume":"198","author":"Malakar\n\u00a0\nS","year":"1999"},{"key":"CIT0135","series-title":"Int J Dermatol","first-page":"649","article-title":"Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)\u2014a prospective study","volume":"45","author":"Lahiri\n\u00a0\nK","year":"2006"},{"key":"CIT0136","series-title":"Indian J Dermatol Venereol Leprol","first-page":"393","article-title":"A study of autologous melanocyte transfer in treatment of stable vitiligo","volume":"71","author":"Pandya\n\u00a0\nV","year":"2005"},{"key":"CIT0137","series-title":"Arch Dermatol","first-page":"1203","article-title":"Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repig- menting vitiligo","volume":"140","author":"van Geel\n\u00a0\nN","year":"2004"},{"key":"CIT0138","series-title":"Int J Dermatol","first-page":"841","article-title":"Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation","volume":"44","author":"Mulekar\n\u00a0\nSV","year":"2005"},{"key":"CIT0139","series-title":"Dermatol Surg","first-page":"436","article-title":"Comparison of minipunch grafting versus split-skin grafting in chronic stable vitiligo","volume":"31","author":"Khandpur\n\u00a0\nS","year":"2005"},{"key":"CIT0140","series-title":"Dermatol Surg","first-page":"49","article-title":"A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo","volume":"30","author":"Barman\n\u00a0\nKD","year":"2004"},{"key":"CIT0141","series-title":"Int J Dermatol","first-page":"649","article-title":"Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)\u2014a prospective study","volume":"45","author":"Lahiri\n\u00a0\nK","year":"2006"},{"key":"CIT0142","series-title":"J Cos- met Dermatol","first-page":"72","article-title":"Camou?age for patients with vitiligo vulgaris improved their quality of life","volume":"9","author":"Tanioka\n\u00a0\nM","year":"2010"},{"key":"CIT0143","series-title":"\u2018La Voce dei Pazienti\u2019. Evidence Based Dermatology","author":"DePase\n\u00a0\nA","year":"2003"},{"key":"CIT0144","series-title":"Dermatology","first-page":"279","article-title":"Quality of life and stig- matization pro?le in a cohort of vitiligo patients and effect of the use of camou?age","volume":"210","author":"Ongenae\n\u00a0\nK","year":"2005"},{"key":"CIT0145","series-title":"Clin Exp Dermatol","first-page":"393","article-title":"The hidden face of dermatology","volume":"18","author":"Savin\n\u00a0\nJ","year":"1993"},{"key":"CIT0146","series-title":"Clin Dermatol","first-page":"30","article-title":"Permanent makeup: indications and complications","volume":"26","author":"De Cuyper\n\u00a0\nC","year":"2008"},{"key":"CIT0147","series-title":"Br J Dermatol","first-page":"669","article-title":"Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature","volume":"97","author":"Mosher\n\u00a0\nDB","year":"1977"},{"key":"CIT0148","series-title":"J Am Acad Dermatol","first-page":"760","article-title":"Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q- switched ruby laser","volume":"42","author":"Njoo\n\u00a0\nMD","year":"2000"},{"key":"CIT0149","series-title":"Dermatol Surg","first-page":"1043","article-title":"Use of the Q-switched 755-nm alexandrite laser to treat recalcitrant pigment after depigmentation therapy for vitiligo","volume":"30","author":"Rao\n\u00a0\nJ","year":"2004"},{"key":"CIT0150","series-title":"J Am Acad Dermatol","first-page":"411","article-title":"The burden of vitiligo: patient characteristics associated with quality of life","volume":"61","author":"Linthorst Homan\n\u00a0\nMW","year":"2009"},{"key":"CIT0151","series-title":"Br J Dermatol","first-page":"481","article-title":"Vitiligo linked to stigmatization in British South Asian women: a qualitative study of the experiences of living with vitiligo","volume":"163","author":"Thompson\n\u00a0\nAR","year":"2010"},{"key":"CIT0152","series-title":"Vitiligo","first-page":"433","article-title":"Psychological interventions","author":"Kostoupolou\n\u00a0\nP","year":"2009"},{"key":"CIT0153","series-title":"Br J Dermatol","first-page":"128","article-title":"Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral center","volume":"161","author":"Kostopolou\n\u00a0\nP","year":"2009"},{"key":"CIT0154","series-title":"Clin Exp Dermatol","first-page":"736","article-title":"Vitiligo is more than skin deep: a survey of members of the Vitiligo Society","volume":"35","author":"Talsania\n\u00a0\nN","year":"2009"},{"key":"CIT0155","series-title":"Int J Dermatol","first-page":"992","article-title":"Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo","volume":"45","author":"Birol\n\u00a0\nA","year":"2006"},{"key":"CIT0156","series-title":"Dermatology","first-page":"234","article-title":"Vitiligo improvement in a patient with ankylosing spondylitis treated with infliximab","volume":"216","author":"Simon\n\u00a0\nJA","year":"2008"},{"issue":"2 Suppl 1","key":"CIT0157","series-title":"J Am Acad Dermatol","first-page":"S57","article-title":"Repigmentation of vitiligo during eflizumab","volume":"59","author":"Wakkee\n\u00a0\nM","year":"2008"},{"key":"CIT0158","series-title":"J Cutan Med Surg","first-page":"172","article-title":"Familial and colocalized psoriasis and vitiligo responding to alefacept","volume":"13","author":"Al-Mutairi\n\u00a0\nN","year":"2009"},{"key":"CIT0159","series-title":"J Dermatol Treat","first-page":"151","article-title":"The Efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients","volume":"17","author":"Radmanesh\n\u00a0\nM","year":"2006"},{"issue":"3","key":"CIT0160","series-title":"Dermatol Online J","first-page":"30","article-title":"Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir","volume":"11","author":"Dogra\n\u00a0\nS","year":"2005"},{"key":"CIT0161","series-title":"J Invest Dermatol","first-page":"758","article-title":"Enhanced integumental and ocular amelanosis following the termination of cyclosporine administration","volume":"88","author":"Pardue\n\u00a0\nSL","year":"1987"},{"issue":"2","key":"CIT0162","series-title":"Skin Ther Letter","first-page":"1","article-title":"Update on new and emerging options for the treatment of vitiligo","volume":"13","author":"Mahmoud\n\u00a0\nCL","year":"2008"},{"issue":"8","key":"CIT0163","series-title":"Int J Dermatol","first-page":"875","article-title":"evaluation of the therapeutic efficacy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream, and dermabrasion combined with topical Placentrex\u00ae gel in localized stable vitiligo","volume":"46","author":"Sethi\n\u00a0\nRR","year":"2007"},{"key":"CIT0164","series-title":"Cochrane Database Syst Rev","first-page":"1","article-title":"for vitiligo","volume":"20","author":"Whitton\n\u00a0\nJ","year":"2010"}],"container-title":["Qatar Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.qscience.com\/view\/journals\/qmj\/2013\/2\/article-10.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.qscience.com\/downloadpdf\/journals\/qmj\/2013\/2\/article-10.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.qscience.com\/downloadpdf\/journals\/qmj\/2013\/2\/article-10.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:15:08Z","timestamp":1777310108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.qscience.com\/view\/journals\/qmj\/2013\/2\/article-10.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":328,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.5339\/qmj.2013.10","relation":{},"ISSN":["2227-0426"],"issn-type":[{"value":"2227-0426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,1]]}}}